Causes and predictors of nonresponse to treatment of intensive care unit-acquired pneumonia

Critical Care Medicine

Volumn 32, Issue 4, 2004, Pages 938-945

  Ioanas, Malina ^a   Ferrer, Miquel ^a   Cavalcanti, Manuela ^a   Ferrer, Ricard ^b   Ewig, Santiago ^c   Filella, Xavier ^a   De La Bellacasa, Jordi Puig ^a   Torres, Antoni ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b Hospital Universitari Parc Taulí   (Spain)

^c Augustinenspital   (Germany)

Author keywords

Intensive care unit acquired pneumonia; Nonresponding pneumonia; Systemic inflammatory response

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ACINETOBACTER BAUMANNII; ADULT; AGED; ANTIBIOTIC THERAPY; ARTERIAL OXYGEN TENSION; ARTICLE; ASPERGILLUS; BACTERIAL PNEUMONIA; BLOOD CULTURE; CITROBACTER FREUNDII; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; FEMALE; FEVER; FOLLOW UP; HAEMOPHILUS INFLUENZAE; HOSPITAL INFECTION; HUMAN; HYPOTHERMIA; INTENSIVE CARE UNIT; KLEBSIELLA OXYTOCA; LEGIONELLA PNEUMOPHILA; LUNG INFILTRATE; LUNG LAVAGE; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORAXELLA CATARRHALIS; MORTALITY; MULTIPLE ORGAN FAILURE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; PUS; RESPIRATORY DISTRESS SYNDROME; SEPTIC SHOCK; SERRATIA MARCESCENS; SERUM; SPAIN; STENOTROPHOMONAS MALTOPHILIA; STREPTOCOCCUS PNEUMONIAE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

AGED; ANTI-BACTERIAL AGENTS; BIOLOGICAL MARKERS; CAUSE OF DEATH; COHORT STUDIES; CROSS INFECTION; DISEASE PROGRESSION; FEMALE; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; INTERLEUKIN-6; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; OXYGEN; PNEUMONIA, BACTERIAL; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RESPIRATION, ARTIFICIAL; SHOCK, SEPTIC; SURVIVAL ANALYSIS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 1842738502     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000114580.98396.91     Document Type: Article

References (38)

1. Fagon JY, Chastre J, Hance AJ, et al: Nosocomial pneumonia in ventilated patients: A cohort study evaluating attributable mortality and hospital stay. Am J Med 1993; 94: 281-288
2. Leu HS, Kaiser DL, Mori M, et al: Hospital-acquired pneumonia: Attributable mortality and morbidity. Am J Epidemiol 1989; 129: 1258-1267
3. Dupont H, Mentec H, Sollet JP, et al: Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator-associated pneumonia. Intensive Care Med 2001; 27: 355-362
4. Crouch Brewer SC, Wunderink RG, Jones CB, et al: Ventilator-associated pneumonia due to Pseudomonas aeruginosa. Chest 1996; 109:1019-1029
5. Alvarez-Lerma F: Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit: ICU-acquired Pneumonia Study Group Intensive Care Med 1996; 22:387-394
6. Marik PE: Fever in the ICU. Chest 2000; 117:855-869
7. Wunderink RG: Ventilator-associated pneumonia: Failure to respond to antibiotic therapy. Clin Chest Med 1995; 16:173-193
8. Ioanas M, Ferrer R, Angrill J, et al: Evaluation of the nonresponding patients with ventilator-associated pneumonia. Clin Pulm Med 2001; 8:290-295
9. Monton C, Torres A, El Ebiary M, et al: Cytokine expression in severe pneumonia: A bronchoalveolar lavage study. Crit Care Med 1999; 27:1745-1753
10. Ruiz M, Torres A, Ewig S, et al: Noninvasive versus invasive microbial investigation in ventilator-associated pneumonia: Evaluation of outcome. Am J Respir Crit Care Med 2000; 162:119-125
11. Woodhead MA, Torres A: Definition and classification of community-acquired and nosocomial pneumonias. In: Pneumonia. Torres A, Woodhead M (Eds). Sheffield, UK, European Respiratory Society Journals, 1997, pp. 1-12
12. Meduri GU, Chastre J: The standardization of bronchoscopic techniques for ventilator-associated pneumonia. Chest 1992; 102(Suppl 1):557S-564S
13. El-Ebiary M, Torres A, González J, et al: Quantitative cultures of endotracheal aspirates for the diagnosis of ventilator-associated pneumonia. Am Rev Respir Dis 1993; 147:1552-1557
14. Hilbert G, Gruson D, Vargas F, et al: Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med 2001; 344:481-487
15. Balows A, Hausler WJJ: Manual of Clinical Microbiology. Fifth Edition. Washington, DC, American Society for Microbiology, 1991
16. Ioanas M, Ferrer R, Angrill J, et al: Microbial investigation in ventilator-associated pneumonia. Eur Respir J 2001; 17:791-801
17. Angrill J, Agusti C, de Celis R, et al: Bronchial inflammation and colonization in patients with clinically stable bronchiectasis. Am J Respir Crit Care Med 2001; 164: 1628-1632
18. American Thoracic Society: Hospital-acquired pneumonia in adults: Diagnosis, assessment of severity, initial antimicrobial therapy, and preventative strategies. A consensus statement. Am J Respir Crit Care Med 1995; 153:1711-1725
19. Arancibia F, Ewig S, Martinez JA, et al: Antimicrobial treatment failures in patients with community-acquired pneumonia: Causes and prognostic implications. Am J Respir Crit Care Med 2000; 162:154-160
20. Bone RC, Balk RA, Cerra FB, et al: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis: The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101:1644-1655
21. Marshall JC, Cook DJ, Christou NV, et al: Multiple organ dysfunction score: A reliable descriptor of a complex clinical outcome. Crit Care Med 1995; 23:1638-1652
22. Knaus WA, Draper EA, Wagner DP, et al: APACHE II: A severity of disease classification system. Crit Care Med 1985; 13: 818-829
23. Murray JF, Matthay MA, Luce JM, et al: An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988; 138:720-723
24. Winer-Muram HT, Rubin SA, Ellis JV, et al: Pneumonia and ARDS in patients receiving mechanical ventilation: Diagnostic accuracy of chest radiography. Radiology 1993; 188: 479-485
25. Meduri GU, Mauldin GL, Wunderink RG, et al: Causes of fever and pulmonary densities in patients with clinical manifestations of ventilator-associated pneumonia. Chest 1994; 106:221-235
26. Celis R, Torres A, Gatell JM, et al: Nosocomial pneumonia: A multivariate analysis of risk and prognosis. Chest 1988; 93:318-324
27. Torres A, Aznar R, Gatell JM, et al: Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am Rev Respir Dis 1990; 142:523-528
28. Bauer TT, Monton C, Torres A, et al: Comparison of systemic cytokine levels in patients with acute respiratory distress syndrome, severe pneumonia, and controls. Thorax 2000; 55:46-52
29. Rixen D, Siegel JH: Metabolic correlates of oxygen debt predict posttrauma early acute respiratory distress syndrome and the related cytokine response. J Trauma 2000; 49: 392-403
30. Bonten MJ, Froon AH, Gaillard CA, et al: The systemic inflammatory response in the development of ventilator-associated pneumonia. Am J Respir Crit Care Med 1997; 156: 1105-1113
31. Antunes G, Evans SA, Lordan JL, et al: Systemic cytokine levels in community-acquired pneumonia and their association with disease severity. Eur Respir J 2002; 20:990-995
32. Root RK, Marrie TJ, Lodato RF, et al: A multicenter, double-blind, placebo-controlled study of the use of Filgastrim in patients hospitalized with pneumonia and severe sepsis. Crit Care Med 2003; 31:367-373
33. Montón C, Ewig S, Torres A, et al: Role of glucocorticoids on inflammatory response in nonimmunosuppressed patients with pneumonia: A pilot study. Eur Respir J 1999; 14:218-220
34. Ibrahim EH, Ward S, Sherman G, et al: Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit Care Med 2001; 29:1109-1115
35. Toikka P, Irjala K, Juven T, et al: Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children. Pediatr Infect Dis J 2000; 19:598-602
36. Hubmayr RD: Statement of the 4th International Consensus Conference in Critical Care on ICU-Acquired Pneumonia: Chicago, Illinois, May 2002. Intensive Care Med 2002; 28:1521-1536
37. Dennesen PJW, van der Ven AJAM, Kessels AGH, et al: Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia. Am J Respir Crit Care Med 2001; 163:1371-1375
38. Luna CM, Blanzaco D, Niederman MS, et al: Resolution of ventilator-associated pneumonia: Prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome. Crit Care Med 2003; 31:676-682